No Data
No Data
Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $55
H.C. Wainwright Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $75
Expert Outlook: CG Oncology Through The Eyes Of 4 Analysts
CG Oncology Price Target Maintained With a $75.00/Share by HC Wainwright & Co.
LifeSci Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $83
Buy Rating for CG Oncology Backed by Promising Phase 3 Study Results and Strong Safety Profile